WINNER | Norwich Pharma Services
CATEGORY | Investment Innovation
FACILITY | Norwich, NY
VICE PRESIDENT OF OPERATIONS | Brian Reid
The Norwich Pharma Services manufacturing facil- ity in Norwich, New York is as varied in its capa- bilities as it is its equipment investment strategy. This dedication to growth through equipment and
technology investment has led to it being recognized as one
of Pharmaceutical Processing’s Facility Excellence Award
winners for 2014.
The facility, which has been in operation since 1976, provides 375,000 square feet of operational space in producing
approximately four billion solid oral dose units per year.
With GMP-compliant equipment and production capabilities
throughout, the facility can handle clinical, commercial and
contract manufacturing within the same walls. This dynamic
helps cut product development and regulatory approval
timeframes, as well as the associated costs.
From buying API to product distribution, the facility offers
Phase I - III product development in solid oral dose tablets
and capsules, as well as liquid doses. Manufacturing operations include blending, encapsulation and coating, as well as
fluid bed, blister packing and liquid fill packaging.
Overall, growth in solid dose products has been stagnant,
with the primary exception being high-potency oncology
products. In responding to this trend, Norwich has invested
in equipment that is sized specifically for handling such products and the smaller batches these compounds represent.
The facility can handle all phases of product development, starting with the pilot and scale-up stages, through
production and including product packaging. And as the
pharmaceutical industry continues to rely more and more
on outsourcing, Norwich’s ability to handle early lifecycle
projects has led to a number of long-term relationships.
Examples of the investments that the Norwich facility has
Norwich Pharma Services
made in order to grow its clinical, commercial and contract
customer base includes:
• 8,000 square feet of DEA-approved solvent and potent com-
pound capable space.
• Two laboratories dedicated to providing solid dose devel-
opment and manufacturing technologies in both R&D and